Bio-Rad Laboratories (BIO-B) Return on Sales (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (up 1.0% YoY), and the FY2025 annual result was 0.0%, up 1.0% from the prior year.
• Return on Sales retreated to 0.01% in Q1 2026 per BIO-B's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q4 2022 and troughed at 0.05% in Q1 2022.
• A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2022 and 2023: Return on Sales dropped 6 bps in 2022, then climbed 5 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then slumped by 55 bps to 0.01% in 2023, then sank by 309 bps to 0.01% in 2024, then soared by 197 bps to 0.01% in 2025, then plunged by 186 bps to 0.01% in 2026.
• Business Quant data shows BIO-B's Return on Sales at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.